House Rx

Other Healthcare Technology Systems · San Francisco, CA · Founded 2021 · Privately Held (backing)

Operator of a technology-enabled service company intended to make specialty medication more accessible and affordable. House Rx is based in San Francisco, CA and was founded in 2021. It was valued at $253 million at its early-stage round in Nov 2025, the last priced event on record. It has raised $84.9 million across 1 recorded round; the latest was a $55 million Series B in Nov 2025.

PMV mark · valuation
$253.0M
Oct 2026
Priced at
its early-stage round
Nov 2025
Total raised
$84.9M
Last round
Early Stage VC (Series B)
Nov 2025
What is House Rx worth?
$253.0MPrivateMarketView mark · Oct 2026

Valued at $253.0M at its early-stage round, Nov 2025. Nothing has traded since.

Free account
More of House Rx with a free account
  • ·The complete investor list: 12 names
  • ·Watch House Rx: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

House Rx funding history

1 rounds
DateRoundRaisedPost-money
Nov 2025Early Stage VC (Series B)$55.0M▮
Unlock post-money valuations

Membership and data by Private Market View

House Rx valuation

House Rx was valued at $253 million at its early-stage round in Nov 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has House Rx raised?

House Rx has raised $84.9 million in total; 1 of its rounds is on record. The largest on record was a $55 million Series B in Nov 2025.

Comparable companies

Comparable other healthcare technology systems names by valuation on PrivateMarketView: Paradigm Health (Healthcare Technology Systems) ($443 million), Big Health ($243 million) and SafelyYou ($206 million).

How House Rx's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For House Rx, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about House Rx

What is House Rx worth?
House Rx is valued at $253.0M as of Oct 2026. Valued at $253.0M at its early-stage round, Nov 2025. Nothing has traded since.
How much has House Rx raised?
House Rx has raised $84.9M in total funding across 1 recorded rounds.
When did House Rx last raise?
House Rx last raised in Nov 2025 (Early Stage VC (Series B)), raising $55.0M.